Preclinical targeting of liver fibrosis with a 89Zr-labeled Fibrobody® directed against platelet derived growth factor receptor-β.
Muns JA, Schooten E, van Dasselaar RDJ, Noordman YE, Adamzek K, Eibergen AC, Pronk SD, Cali S, Sijbrandi NJ, Merkul E, Oliveira S, van Bergen En Henegouwen PMP, Takkenberg RB, Verheij J, van de Graaf SFJ, Nijmeijer BA, van Dongen GAMS.
Muns JA, et al. Among authors: adamzek k.
Eur J Nucl Med Mol Imaging. 2024 Oct;51(12):3545-3558. doi: 10.1007/s00259-024-06785-9. Epub 2024 Jun 18.
Eur J Nucl Med Mol Imaging. 2024.
PMID: 38888612
Free PMC article.